Julian Heslop

Julian Heslop

No open positions remaining

Net worth: 120 481 $ as of 2026-05-30

72 year
Health Technology
Commercial Services
Consumer Non-Durables

Profile

Julian Spenser Heslop formerly worked at ViiV Healthcare Ltd., as Chairman, Genelabs Technologies, Inc., as Chief Financial Officer & Executive Director, GSK Plc, as Chief Financial Officer & Executive Director in 2011, Dechra Pharmaceuticals Plc, as Independent Non-Executive Director from 2013 to 2022, The Royal Academy of Arts, as Director, Itaconix Plc, as Independent Non-Executive Director from 2012 to 2018, Glaxo Wellcome Plc, as Financial Controller from 1998 to 2000, Grand Metropolitan Plc, as Controller, and Stoy Hayward Ltd., as Auditor in 1979.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
0.04%
2025-10-31 95,000 ( 0.04% ) 68 509 $ 2026-05-30
0.03%
2026-02-28 102,000 ( 0.03% ) 51 972 $ 2026-05-30

Former positions of Julian Heslop

CompaniesPositionEnd
DECHRA PHARMACEUTICALS Director/Board Member 2022-09-04
ITACONIX PLC Director/Board Member 2018-10-01
GSK PLC Director of Finance/CFO 2011-03-30
Chairman 2011-02-28
Comptroller/Controller/Auditor 1999-12-31
See the detail of Julian Heslop's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

67

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Non-Durables

Commercial Services

Commercial Services

Process Industries

Health Technology